BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4800904)

  • 1. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes.
    Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):503-10. PubMed ID: 4868496
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids.
    Field JB; Remer A; Bloom G; Kriss JP
    J Clin Invest; 1968 Jul; 47(7):1553-60. PubMed ID: 5658587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding.
    von Westarp C; Knox AJ; Row VV; Volpé R
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):759-67. PubMed ID: 576759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-acting thyroid stimulator on the reorganization into follicles of isolated thyroid cells and on the binding of radioiodinated thyrotropin to reassociated cells.
    Fayet G; Verrier B; Giraud A; Lissitzky S; Pinchera A; Romaldini JH; Fenzi G
    FEBS Lett; 1973 Jun; 32(2):299-302. PubMed ID: 4354817
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and immunologic aspects of the relation of acquired leukoderma (vitiligo) to thyroid diseases.
    Miklaszewska M; Zukowski W; Dankiewicz J; Nowak A
    Arch Immunol Ther Exp (Warsz); 1972; 20(6):885-92. PubMed ID: 4123759
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitivity and specificity of blood and thyroid radio-iodine assays for TSH and LATS and inhibitory effect of corticosteroid.
    Sharard A
    N Z Med J; 1975 Jan; 81(531):21-2. PubMed ID: 1055309
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F; Schleusener H; Uher L; Ananos A
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid responsiveness in Gravesian ophthalmopathy.
    Mendelsohn LV; Mouton DE; Goldzieher JW
    Arch Intern Med; 1972 Jul; 130(1):119-20. PubMed ID: 5067864
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
    Kendall-Taylor P
    Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symposium: action mechanism of hormones. 3. Action mechanism of TSH and LATS].
    Koshichi Y
    Nihon Naibunpi Gakkai Zasshi; 1970 Feb; 45():Suppl:22-3. PubMed ID: 5462193
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of action of di-iodotyrosine and of iodine.
    Fôldes J; Gesztesi E; Juhász J
    Acta Med Acad Sci Hung; 1974; 31(1-2):131-7. PubMed ID: 4464746
    [No Abstract]   [Full Text] [Related]  

  • 15. [LATS and other antibodies against the TSH receptor].
    Rodríguez Zapata MM
    Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].
    Sussi PL; Burro A; Plebani M; Abrescia F; Perazzolo E; Petronio R
    Chir Ital; 1984 Aug; 36(4):643-7. PubMed ID: 6549274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
    Brown J; Ensor J; Munro DS
    Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR; Hall R
    Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulation of thyroid hyperplasia and protein synthesis by LATS.
    Ochi Y; DeGroot LJ
    Endocrinology; 1969 Aug; 85(2):344-7. PubMed ID: 5784922
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of proteolysis in the mouse thyroid gland by thyrotropin and the long-acting thyroid stimulator: comparison of intact lobe and homogenate.
    Konno N; Murthy PV; McKenzie JM
    Endocrinology; 1970 Nov; 87(5):1062-8. PubMed ID: 5482934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.